Theravance Biopharma
new era in treating symptoms product positioning | Theravance Biopharma
Company
Deck Type
Sector
Industry
Deck date
April 2023
Slide
10 of 32
Similar slides by Theravance Biopharma
See diffirences between slides (animation)
Results
August 2023
symptoms of in significant unmet need | Theravance Biopharma
Results
May 2023
new era in treating symptoms product positioning | Theravance Biopharma
Results
February 2023
new era in treating symptoms product positioning | Theravance Biopharma
Related slides by other companies
AstraZeneca
Investor Event
June 2023
phase trial design | AstraZeneca
Ocuphire Pharma
Results
January 2023
has potential to be early preventative therapy for patients | Ocuphire Pharma
Oculis
Investor Conference
June 2023
is a large and growing market with critical unmet needs | Oculis
Erasca
Investor Presentation
November 2023
phase patients continuing on treatment on potential for confirmation of dor and advantage in seacraft | Erasca
Other recent decks by Theravance Biopharma
See all presentations (5 decks)
Results
August 2023
Results
May 2023
Results
February 2023
Investor Conference
November 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights